Evidence map›Paper›PMID 31877112›Full record

ArticleThe Journal of clinical investigation2020

Microphthalmia transcription factor expression contributes to bone marrow failure in Fanconi anemia.

Alessia Oppezzo, Julie Bourseguin, Emilie Renaud, Patrycja Pawlikowska, Filippo Rosselli

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alessia OppezzoCNRS UMR8200 Equipe Labellisée "La Ligue Contre le Cancer,".
Julie BourseguinCNRS UMR8200 Equipe Labellisée "La Ligue Contre le Cancer,".
Emilie RenaudCNRS UMR8200 Equipe Labellisée "La Ligue Contre le Cancer,".
Patrycja PawlikowskaCNRS UMR8200 Equipe Labellisée "La Ligue Contre le Cancer,".
Filippo RosselliCNRS UMR8200 Equipe Labellisée "La Ligue Contre le Cancer,".
Université Paris-Saclay · FRInstitut Gustave Roussy · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hematopoietic stem cell (HSC) attrition is considered the key event underlying progressive BM failure (BMF) in Fanconi anemia (FA), the most frequent inherited BMF disorder in humans. However, despite major advances, how the cellular, biochemical, and molecular alterations reported in FA lead to HSC exhaustion remains poorly understood. Here, we demonstrated in human and mouse cells that loss-of-function of FANCA or FANCC, products of 2 genes affecting more than 80% of FA patients worldwide, is associated with constitutive expression of the transcription factor microphthalmia (MiTF) through the cooperative, unscheduled activation of several stress-signaling pathways, including the SMAD2/3, p38 MAPK, NF-κB, and AKT cascades. We validated the unrestrained Mitf expression downstream of p38 in Fanca-/- mice, which display hallmarks of hematopoietic stress, including loss of HSC quiescence, DNA damage accumulation in HSCs, and reduced HSC repopulation capacity. Importantly, we demonstrated that shRNA-mediated downregulation of Mitf expression or inhibition of p38 signaling rescued HSC quiescence and prevented DNA damage accumulation. Our data support the hypothesis that HSC attrition in FA is the consequence of defects in the DNA-damage response combined with chronic activation of otherwise transiently activated signaling pathways, which jointly prevent the recovery of HSC quiescence.

Indexed as

DNA DamageMAP Kinase Signaling SystemAnimalsAscorbic AcidBone Marrow Failure DisordersCell LineCholecalciferolDehydroepiandrosteroneExtracellular Signal-Regulated MAP KinasesFanconi AnemiaFanconi Anemia Complementation Group ProteinsHematopoietic Stem CellsMiceMice, KnockoutMicrophthalmia-Associated Transcription FactorNicotinic AcidsAscorbic AcidCholecalciferolDehydroepiandrosteroneExtracellular Signal-Regulated MAP KinasesFanconi Anemia Complementation Group ProteinsHUM 5007Microphthalmia-Associated Transcription FactorMITF protein, humanMitf protein, mouseNicotinic AcidsPlant ExtractsSmad ProteinsBone marrowCell BiologyDNA repairGenetic diseasesHematology

Identifiers

PMID31877112
PMCPMC7269568
OpenAlexW2997124786

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.